drugset / Trial / NCT01106664
ONO-7746 Study in Healthy Adult Subject
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this study is to evaluate the safety and tolerability of NON-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746 and to evaluate the food effect on the PK profile of ONO-7746 when administered with or without a meal.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ONO-7746 | Unknown | 1 mg | — |
| Subject | ONO-7746 | Unknown | 2 mg | — |
| Subject | ONO-7746 | Unknown | 4 mg | — |
| Subject | ONO-7746 | Unknown | 8 mg | — |
| Subject | ONO-7746 | Unknown | 16 mg | — |
Indications
No indication recorded.